Skip to main content
Jared Weiss, MD, Oncology, Chapel Hill, NC

Jared M Weiss MD

Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer


Physician

Join to View Full Profile
  • 101 Manning DrChapel Hill, NC 27514

  • Phone+1 984-974-0000

  • Fax+1 984-974-2607

Dr. Weiss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
  • Yale School of Medicine
    Yale School of MedicineClass of 2004

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2010 - 2026
  • PA State Medical License
    PA State Medical License 2007 - 2010
  • MA State Medical License
    MA State Medical License 2006 - 2009
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
  • CMS Meaningful Use Stage 1 Certification WebCIS, UNC Health Care, 2012, 2014-2017

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Preliminary toxicity data from the combination of pembrolizumab and definitive-dose radiotherapy for locally advanced head and neck cancer with contraindication to cis... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
  • Postoperative Chemoradiation: Which Patients, Which Agents? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/1/2018

Press Mentions

  • After Revolutionizing Blood Cancer Care, CAR-T Therapy Takes Aim at Solid Tumors
    After Revolutionizing Blood Cancer Care, CAR-T Therapy Takes Aim at Solid TumorsAugust 18th, 2025
  • Survival in Small-Cell Lung Cancer Improved with Cytotoxic Add-on to Immunotherapy
    Survival in Small-Cell Lung Cancer Improved with Cytotoxic Add-on to ImmunotherapyMay 22nd, 2025
  • Warning on Use of Sotorasib After ICI in Lung Cancer
    Warning on Use of Sotorasib After ICI in Lung CancerJune 1st, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: